1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
Motherisk Update 2014
Fetal Alcohol Canadian Expertise (FACE) Satellite Meeting,
Details to be announced
- Read more in our News Archive
Current Studies at Motherisk
Neurodevelopment of Children Exposed in-Utero to Chemotherapy for Maternal Breast Cancer (Dr. I Nulman)
Diclegis Surveillance Program Study
Diclectin Surveillance Program Study
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
Pregnancy in Women with Multiple Sclerosis
Environmental Exposures and Children's Health
Alcohol Use during Pregnancy
Control of Hypertension in Pregnancy Study
Folic Acid Before and During Pregnancy
Lamisil in Pregnancy
Meridia in Pregnancy
Autoimmune Diseases in Pregnancy Project
The Cancer in Pregnancy ForumArchived Questions and Answers
This Forum has been the centre of an exceptional exchange of knowledge diagnosis, treatment, symptoms and other effects of cancer during pregnancy and lactation. All are welcome to review the Questions and Answers posted here, provided that they acknowledge and accept the important proviso and disclaimer below.
I was diagnosed with breast cancer last year and underwent a Mystecomy,chemo and radiation. I had some eggs frozen before starting any treatments. My breast cancer was estrogen positive and found in 4 out of 6 lypnodes taken. My question is do I stand a risk for reoccurence if I wanted to get pregnant? and how long should I be off of the Tamoxfien before trying invitro?
The following information should not replace the assessment and advice you have been receiving from your physician (cancer specialist, obstetrician, or any other healthcare provider). It is offered for your information only. Consult your physician.
Not knowing the details of your current clinical status we can only offer general observations. Most young patients with breast cancer in pregnancy are ER receptor positive. This does not adversely affect their clinical course. Theoretically, if a patient is in remission long enough (>2-3 years), future pregnancy should not increase the risk of recurrence. We are not aware of the effect of tamoxifen on pregnancy. It is not recommended for use during pregnancy and should probably be discontinued several months before conception.